0.22
0.22 (0%)
As of Apr 17, 2025
Glycomimetics Inc [GLYC]
Source:
Company Overview
Glycomimetics Inc is a biotechnology company that was previously developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.
| Country | United States |
| Headquarters | rockville, maryland |
| Phone Number | (240) 243-1201 |
| Industry | manufacturing |
| CEO | Harout Semerjian |
| Website | www.glycomimetics.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-40 |
| Net Income | $-37.9 |
| Net Cash | $-31.1 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -134.3% |
| Profit as % of Stockholder Equity | -712.9% |
Management Effectiveness
| Return on Equity | -712.9% |
| Return on Assets | -341.5% |
| Turnover Ratio | |
| EBITA | $-40 |
Balance Sheet and Cash Flow Measures
| Total Assets | $11.1 |
| Total Liabilities | $5.8 |
| Operating Cash Flow | $-31.1 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
